{
  "disease": "Adrenal Tumors",
  "mcqs": [
    {
      "question": "Which tumor accounts for approximately 90% of adrenal malignancies in childhood?",
      "options": {
        "A": "Neuroblastoma",
        "B": "Adrenocortical tumors",
        "C": "Pheochromocytoma",
        "D": "Wilms tumor"
      },
      "correct_answer": "A",
      "explanation": "Neuroblastoma accounts for approximately 90% of adrenal malignancies in childhood."
    },
    {
      "question": "From which cells is neuroblastoma derived?",
      "options": {
        "A": "Neural crest cells of the sympathetic nervous system",
        "B": "Adrenal cortex steroid-producing cells",
        "C": "Chromaffin cells of the adrenal medulla",
        "D": "Mesodermal cells of the adrenal cortex"
      },
      "correct_answer": "A",
      "explanation": "Neuroblastoma is derived from neural crest cells of the sympathetic nervous system."
    },
    {
      "question": "Which histological features are characteristic of neuroblastoma?",
      "options": {
        "A": "Small round blue cells, Homer-Wright rosettes, neuropil background",
        "B": "Atypical nuclei, mitotic figures, venous invasion",
        "C": "Well-differentiated cortical cells, minimal atypia",
        "D": "Hemorrhagic, lobulated mass with calcifications"
      },
      "correct_answer": "A",
      "explanation": "Neuroblastoma is characterized by small round blue cells, Homer-Wright rosettes, and a neuropil background."
    },
    {
      "question": "What sign is associated with neuroblastoma and is referred to as 'raccoon eyes'?",
      "options": {
        "A": "Periorbital ecchymosis",
        "B": "Opsoclonus-myoclonus-ataxia syndrome",
        "C": "Hypertension",
        "D": "Abdominal mass crossing midline"
      },
      "correct_answer": "A",
      "explanation": "Periorbital ecchymosis, known as 'raccoon eyes,' is a sign associated with neuroblastoma."
    },
    {
      "question": "What is the initial imaging modality for evaluating an abdominal mass in pediatric adrenal tumors?",
      "options": {
        "A": "Ultrasound",
        "B": "CT/MRI",
        "C": "123I-MIBG scintigraphy",
        "D": "PET-CT"
      },
      "correct_answer": "A",
      "explanation": "Ultrasound is used for the initial evaluation of an abdominal mass."
    },
    {
      "question": "What is the recommended management for low-risk neuroblastoma?",
      "options": {
        "A": "Observation alone",
        "B": "Chemotherapy",
        "C": "Myeloablative therapy with autologous stem cell rescue",
        "D": "Surgical resection"
      },
      "correct_answer": "A",
      "explanation": "For low-risk neuroblastoma, consider observation as long as no tumour burden symptoms, otherwise if tumour progresses and symptoms appear, biopsy or resect and reclassify with biomarkers."
    },
    {
      "question": "What is the 5-year survival rate for low-risk neuroblastoma?",
      "options": {
        "A": ">95%",
        "B": "40-50%",
        "C": "50-80%",
        "D": "15-50%"
      },
      "correct_answer": "A",
      "explanation": "Low-risk neuroblastoma has a 5-year survival rate of over 95%."
    },
    {
      "question": "Which genetic mutation is most commonly associated with pediatric adrenocortical tumors?",
      "options": {
        "A": "TP53 germline mutations",
        "B": "ALK mutations",
        "C": "PHOX2B mutations",
        "D": "RET mutations"
      },
      "correct_answer": "A",
      "explanation": "TP53 germline mutations are present in 70-80% of pediatric adrenocortical tumor cases."
    },
    {
      "question": "What is the sensitivity of MIBG scintigraphy for neuroblastoma?",
      "options": {
        "A": "90%",
        "B": "70%",
        "C": "50%",
        "D": "30%"
      },
      "correct_answer": "A",
      "explanation": "MIBG scintigraphy has 90% sensitivity for neuroblastoma."
    },
    {
      "question": "Which syndrome is associated with adrenocortical tumors?",
      "options": {
        "A": "Beckwith-Wiedemann syndrome",
        "B": "Neurofibromatosis type 1",
        "C": "Hirschsprung disease",
        "D": "Multiple Endocrine Neoplasia type 2"
      },
      "correct_answer": "A",
      "explanation": "Beckwith-Wiedemann syndrome is associated with adrenocortical tumors."
    },
    {
      "question": "What is the surgical mortality rate for adrenal tumor resection in specialized centers?",
      "options": {
        "A": "<2%",
        "B": "3-8%",
        "C": "5-10%",
        "D": "15-50%"
      },
      "correct_answer": "A",
      "explanation": "Surgical mortality is less than 2% in specialized centers."
    },
    {
      "question": "What is the 5-year survival rate for adrenocortical carcinoma with complete resection?",
      "options": {
        "A": "50-80%",
        "B": ">95%",
        "C": "40-50%",
        "D": "15-50%"
      },
      "correct_answer": "A",
      "explanation": "Adrenocortical carcinoma has a 5-year survival rate of 50-80% with complete resection."
    },
    {
      "question": "During which weeks of gestation do neural crest cells migrate to form sympathetic ganglia and adrenal medulla?",
      "options": {
        "A": "Weeks 1–4",
        "B": "Weeks 5–12",
        "C": "Weeks 13–20",
        "D": "Weeks 21–28"
      },
      "correct_answer": "B",
      "explanation": "Neural crest cells migrate to form sympathetic ganglia and adrenal medulla during weeks 5–12 of gestation."
    },
    {
      "question": "What is a common paraneoplastic syndrome associated with neuroblastoma?",
      "options": {
        "A": "Cushing syndrome",
        "B": "Opsoclonus-myoclonus-ataxia syndrome",
        "C": "Syndrome of inappropriate antidiuretic hormone secretion",
        "D": "Horner syndrome"
      },
      "correct_answer": "B",
      "explanation": "Opsoclonus-myoclonus-ataxia syndrome occurs in 2–4% of neuroblastoma cases due to autoimmune cross-reactivity."
    },
    {
      "question": "Which molecular alteration is associated with poor prognosis in neuroblastoma?",
      "options": {
        "A": "ALK mutation",
        "B": "MYCN amplification",
        "C": "TERT rearrangement",
        "D": "PHOX2B mutation"
      },
      "correct_answer": "B",
      "explanation": "MYCN amplification drives cell cycle progression and genomic instability, and is associated with poor prognosis in neuroblastoma."
    },
    {
      "question": "According to the International Neuroblastoma Risk Group (INRG) classification, what is the 5-year survival for high-risk neuroblastoma?",
      "options": {
        "A": ">95%",
        "B": "85–95%",
        "C": "50–60%",
        "D": "20–30%"
      },
      "correct_answer": "C",
      "explanation": "High-risk neuroblastoma has a 5-year survival of 50–60%."
    },
    {
      "question": "In what percentage of neuroblastoma cases are urinary catecholamines elevated?",
      "options": {
        "A": "50%",
        "B": "70%",
        "C": "90%",
        "D": "100%"
      },
      "correct_answer": "C",
      "explanation": "Urinary catecholamines, including homovanillic acid and vanillylmandelic acid, are elevated in 90% of neuroblastoma cases."
    },
    {
      "question": "Which imaging modality is positive in more than 90% of neuroblastoma cases for staging and response assessment?",
      "options": {
        "A": "Ultrasound",
        "B": "CT scan",
        "C": "MIBG scintigraphy",
        "D": "MRI"
      },
      "correct_answer": "C",
      "explanation": "MIBG scintigraphy is positive in >90% of neuroblastoma cases and is used for staging and response assessment."
    },
    {
      "question": "Which tumor is typically intrarenal, unlike neuroblastoma?",
      "options": {
        "A": "Rhabdomyosarcoma",
        "B": "Lymphoma",
        "C": "Wilms tumor",
        "D": "Ewing sarcoma"
      },
      "correct_answer": "C",
      "explanation": "Wilms tumor is typically intrarenal, unlike neuroblastoma."
    },
    {
      "question": "What does INRG stage MS indicate in neuroblastoma?",
      "options": {
        "A": "Localized tumor without image-defined risk factors",
        "B": "Localized tumor with risk factors",
        "C": "Distant metastasis",
        "D": "Metastatic disease in children <18 months with specific sites"
      },
      "correct_answer": "D",
      "explanation": "INRG stage MS indicates metastatic disease in children under 18 months with specific sites such as skin or liver."
    },
    {
      "question": "What is the 5-year survival for intermediate-risk neuroblastoma?",
      "options": {
        "A": ">95%",
        "B": "85–90%",
        "C": "70–80%",
        "D": "50–60%"
      },
      "correct_answer": "B",
      "explanation": "Intermediate-risk neuroblastoma has a 5-year survival of 85–90%."
    }
  ]
}